Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients.

Authors
Type
Published Article
Journal
Hepatology research : the official journal of the Japan Society of Hepatology
Publication Date
Volume
44
Issue
10
Identifiers
DOI: 10.1111/hepr.12268
PMID: 24397402
Source
Medline
Keywords
License
Unknown

Abstract

Compared to triple therapy including telaprevir 2250 mg/day, that including telaprevir at a reduced dose of 1500 mg/day was associated with lower rates of anemia and similar antiviral efficacy. Such a regimen may meaningfully improve sustained virological response rates, especially among female and elderly Japanese patients.

Statistics

Seen <100 times